Takeda · 1 day ago
Sr. Manager, In Silico First Program & Strategy Management
Boston, MA
Full-time
Hybrid
Mid, Senior Level
$137K/yr - $235K/yr
2+ years expTakeda Development Center Americas, Inc. is seeking a Sr. Manager, In Silico First Program & Strategy Management to independently manage roadmaps and strategic plans for the ISF program. The role involves overseeing day-to-day operations, collaborating with stakeholders, and driving the adoption of innovative methodologies while ensuring regulatory compliance.
BiotechnologyHealth CareManufacturingMedicalPharmaceutical
Responsibilities
Independently manage roadmaps and strategic plans to advance the ISF program, in alignment with company goals and objectives
Oversee day-to-day operations of the initiative, ensuring smooth execution and timely delivery of projects
Collaborate with and influence stakeholders, including the PharmSci Capability Owners in the global suites as well as the local functional teams to ensure initiative alignment and scalability across the global framework
Foster cross-functional collaboration to drive the adoption of innovative methodologies while maintaining regulatory compliance where only recent guidance is available and is evolving
Establish and monitor performance metrics to gauge the success and ROI of the ISF roadmap and ensure alignment with strategic business goals
Lead resource planning, budget management, and timelines across Pharm Sci functional areas
Manage with close support external vendor partnerships to enhance execution & scalability of PSST initiatives
Support Change Management efforts to facilitate smooth transitions to new processes & technologies, ensuring stakeholder engagement & minimizing disruptions
Drive strategic communication efforts to ensure clear understanding and support of the In Silico First paradigm by and across the organization
Provide technical expertise in in silico model development, ensuring the application of best practices and cutting-edge methodologies
Serve as an embedded in silico Subject Matter expert in select lighthouse projects
Drive the development and validation of computational models, leveraging deep expertise in silico approaches
Ensure the integration of in silico models with experimental data and workflows to enhance predictive accuracy and reliability and ensure increased productivity
Qualification
Required
Ph.D. in Pharmacy and Biomedical Sciences or related field
2 years of related experience
Contribute to the creating of global strategic roadmaps and frameworks (such as the Pharm Sci Digital Strategy and R&D Integrated Digital Strategy)
Effectively managing project timelines and deliverables
Planning and coordinating projects with departmental, functional, and external stakeholders
Lead change management strategy for In Silico First and Aedifica Fortis
Managing close collaboration with external vendors to enhance execution of these strategies
Oversee day-to-day operations of the Aedifica fortis portfolio for Pharm Sci
Ensuring strategic alignment, successful execution and timely delivery of projects
Drive technical projects for the In Silico First initiative
Integrates in silico models with experimental data and workflows to enhance predictive accuracy and reliability
Ensure increased productivity and reduced resource and time consumption
Company
Takeda
Takeda is a biopharmaceutical company that researches and develops pharmaceutical drugs.
10001+ employees
H1B Sponsorship
Takeda has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (45)
2024 (39)
2023 (38)
2022 (34)
2021 (44)
2020 (18)
Funding
Current Stage
Public CompanyTotal Funding
$2.46B2025-06-27Post Ipo Debt· $2.4B
2016-09-01Grant· $19.8M
2016-05-08Grant· $38M
Leadership Team
Christophe Weber
President and CEO
Schuyler Fairfield
Senior Vice President, Global Head of Supply Chain
Recent News
Pharma Letter
2026-01-03
2025-12-30
Company data provided by crunchbase